Shares in BioNTech, the company that partnered with Pfizer to bring the world COVID shots, have tanked over the past six months, records show.
From a high of almost $400 in the fall of 2021, they have dropped by $233.29, a loss of 61.05% of their value, and appear to be likely to drop still further.